Shankar Venkatraman
Ifm Therapeutics (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Bone Metabolism and Diseases, Protease and Inhibitor Mechanisms, Chemical Synthesis and Analysis, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → The cGAS–STING pathway as a therapeutic target in inflammatory diseases(2021)2,056 cited
- → Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease(2013)132 cited
- → Design and Synthesis of Tri-Ring P3 Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K(2005)94 cited
- → A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K(2003)82 cited
- → The discovery of fused pyrrole carboxylic acids as novel, potent d-amino acid oxidase (DAO) inhibitors(2008)82 cited
- → The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine(2008)81 cited
- → Synthesis and Evaluation of Peptidyl Michael Acceptors That Inactivate Human Rhinovirus 3C Protease and Inhibit Virus Replication(1998)59 cited
- → Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold(2010)57 cited
- → An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells(2004)52 cited
- → Synthesis and Dopamine Receptor Modulating Activity of Novel Peptidomimetics ofl-Prolyl-l-leucyl-glycinamide Featuring α,α-Disubstituted Amino Acids(1999)48 cited